Role of the peripheral chemoreceptors in cardiovascular and metabolic control in type 2 diabetes

Jacqueline K. Limberg; Elizabeth P. Ott; Aubrey M. Pipkins; Eric C. Lis; Anna Gonsalves; Jennifer L. Harper; Camila Manrique‐Acevedo

doi:10.1113/jp286975

August 28, 2024The Journal of Physiology

Role of the peripheral chemoreceptors in cardiovascular and metabolic control in type 2 diabetes

View at Publisher

Ask AI

Bookmark

Share

Key Points

Peripheral chemoreceptors were evaluated for their suspected contribution to resting cardiovascular dysfunction and altered metabolic control in type 2 diabetes.
Glycated haemoglobin reached 7.6 ± 1.5% in 17 adults with type 2 diabetes, compared with 5.2 ± 0.4% measured across 20 control participants.
Assessment using the hypoxic ventilatory response evaluated peripheral chemosensitivity, highlighting potential mechanisms behind metabolic impairment.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Comparative physiological study examines peripheral chemoreceptor sensitivity in type 2 diabetes, suggesting pathways linking chemoreflexes to cardiovascular dysfunction.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Limberg et al. (2024) studied this question.

synapsesocial.com/papers/68e5a81fb6db643587542a14 https://doi.org/10.1113/jp286975

View at Publisher

Ask AI

Bookmark

Share

Role of the peripheral chemoreceptors in cardiovascular and metabolic control in type 2 diabetes

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Role of the peripheral chemoreceptors in cardiovascular and metabolic control in type 2 diabetes

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading